Breast Cancer Update.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
Read Online Read More Add to Saved list
  • Additional Information
    • Subject Terms:
      UNITED States
    • Subject Terms:
      GLAXOSMITHKLINE ; UNITED States. Food & Drug Administration ; CASI Pharmaceuticals Inc. 796176915 ENMD
    • Abstract:
      The article presents news related to researches in breast cancer. A phase II trial to evaluate experimental anticancer drug Tykerb for the treatment of breast cancer that has metastasized to the brain, has been initiated by GlaxoSmithKline PLC. Biopharmaceutical Bioenvision has enrolled patients into its efficacy studies of its licensed breast cancer therapy. The U.S. Food and Drug Administration has accepted EntreMed Inc.'s investigational new drug application for ENMD-1198, a novel tubulin binding agent that the company wishes to move into clinical development for the treatment of cancer.